A special sugar in breast milk called 3’-sialyllactose helps newborn babies’ intestines mature and prevents jaundice, according to Gram Research analysis of a 2026 study in mice. Babies lacking this milk component developed worse jaundice, had immature intestines, and showed reduced survival rates. The sugar activates genes that help babies’ guts clear bilirubin, the yellow substance causing jaundice. This research supports breastfeeding’s critical role in newborn health during the first weeks of life.
A new study shows that a special sugar found in breast milk called 3’-sialyllactose helps newborn babies’ intestines develop properly and prevents dangerous jaundice. Researchers used mice to discover that this milk sugar activates important genes that help babies’ guts mature and clear bilirubin, a yellow substance that causes jaundice. The findings suggest that breast milk contains natural ingredients specifically designed to protect newborns during their first critical weeks of life. This research could help doctors better understand why breastfeeding is so important for newborn health.
Key Statistics
A 2026 research article found that newborn mice deprived of the breast milk sugar 3’-sialyllactose showed reduced survival rates, growth retardation, and significantly worsened jaundice compared to mice receiving normal maternal milk.
According to the 2026 study, baby mice lacking the milk sugar 3’-sialyllactose had markedly decreased intestinal UGT1A1 enzyme expression, the protein responsible for clearing bilirubin and preventing jaundice.
Research published in 2026 demonstrated that mice deprived of maternal milk 3’-sialyllactose in infancy exhibited heightened susceptibility to intestinal injury in adulthood, suggesting early nutrition shapes lifelong gut resilience.
A 2026 study found that the milk sugar 3’-sialyllactose works through HNF4α signaling to promote development of specialized intestinal cells including goblet cells and Paneth cells that protect newborn gut health.
The Quick Take
- What they studied: Whether a specific sugar in breast milk helps newborn babies’ intestines develop properly and prevents jaundice, a condition that makes babies’ skin turn yellow.
- Who participated: Newborn mice that were genetically modified to develop jaundice naturally, allowing researchers to study how breast milk components affect intestinal development and bilirubin clearance.
- Key finding: Baby mice that received breast milk containing the sugar 3’-sialyllactose had healthier intestines, better survival rates, and less severe jaundice compared to those without this milk component.
- What it means for you: This research supports the importance of breastfeeding for newborn health, particularly in preventing jaundice and supporting proper gut development. However, this is animal research, so more studies in human babies are needed before making clinical recommendations.
The Research Details
Researchers used specially bred mice that naturally develop jaundice like human newborns do. They compared baby mice that received normal breast milk to those whose mothers’ milk lacked a specific sugar called 3’-sialyllactose. The scientists measured intestinal development, bilirubin levels, and gene expression in the babies’ guts. They also followed some mice into adulthood to see if early milk deprivation had lasting effects on intestinal health. The study combined multiple laboratory techniques including genetic analysis, protein detection, and tissue examination to understand exactly how this milk sugar works.
This research approach is important because it identifies a specific component of breast milk and shows exactly how it protects newborns. By using mice that naturally develop jaundice, researchers could study the problem in a controlled way that would be impossible in human babies. The study also looked at long-term effects, showing that early nutrition impacts gut health throughout life.
This is original research published in a peer-reviewed scientific journal. The study used multiple complementary methods to confirm findings, which strengthens confidence in the results. However, because this is animal research in mice, the findings need to be confirmed in human studies before applying them to clinical practice. The researchers used genetically modified mice, which may not perfectly mirror human newborn biology.
What the Results Show
Baby mice that lacked the milk sugar 3’-sialyllactose showed several serious problems compared to normal mice. They had reduced survival rates, grew more slowly, had shorter intestines, and developed worse jaundice. The researchers found that these babies’ intestines produced much less of an enzyme called UGT1A1, which is crucial for clearing bilirubin from the body. Gene analysis revealed that the intestines of milk-deprived babies failed to mature properly. Instead of developing the specialized cells needed for a healthy gut, these intestines activated genes that are normally only active before birth, suggesting their intestines remained immature.
The study found that two specific cell types in the intestine were particularly affected: goblet cells and Paneth cells, which produce protective mucus and antibacterial substances. These cells were significantly reduced in babies lacking the milk sugar. Additionally, when researchers followed mice into adulthood, those who had been deprived of this milk sugar in infancy showed greater damage to their colons when exposed to inflammatory triggers, suggesting that early nutrition shapes lifelong intestinal resilience.
Previous research has shown that breast milk oligosaccharides, the family of sugars that includes 3’-sialyllactose, support infant gut health. This study provides specific mechanistic evidence for how one particular sugar works and identifies the genetic pathways involved. The findings align with epidemiological data showing that breastfed infants have lower rates of jaundice and better long-term digestive health compared to formula-fed infants.
This research was conducted in mice, not human babies, so results may not directly translate to human infants. The study used genetically modified mice that develop jaundice more severely than typical human newborns, which may exaggerate the effects of milk sugar deprivation. The study did not examine whether supplementing formula with this milk sugar could produce similar benefits. Additionally, the research focused on one specific milk component, while breast milk contains hundreds of bioactive compounds that likely work together.
The Bottom Line
This research supports current medical guidance recommending breastfeeding for newborn health, particularly for preventing jaundice and supporting intestinal development. For mothers who cannot breastfeed, this research highlights the importance of working with healthcare providers to ensure infants receive appropriate nutrition. The findings suggest that the specific components of breast milk are uniquely suited to newborn needs, though human studies are needed to confirm whether adding this sugar to formula would be beneficial. Confidence level: Moderate, based on animal research requiring human confirmation.
This research is most relevant to new parents, pediatricians, neonatologists, and lactation specialists. It’s particularly important for families with a history of severe jaundice or those considering feeding options for newborns. Healthcare providers may use this information to better counsel parents about breastfeeding benefits. This research is less immediately relevant to parents of older children or adults, though it suggests that early nutrition affects lifelong gut health.
The protective effects of this milk sugar appear to be most critical during the first weeks of life when newborn jaundice typically develops. The study suggests that benefits extend throughout life, as mice deprived of this sugar in infancy showed greater intestinal vulnerability in adulthood. Realistic expectations include improved jaundice outcomes within the first 1 to 2 weeks of life if breastfeeding is established successfully.
Frequently Asked Questions
Does breastfeeding prevent jaundice in newborns?
Research shows breast milk contains protective components like 3’-sialyllactose that support intestinal maturation and bilirubin clearance, reducing jaundice severity. A 2026 study found babies lacking this milk sugar developed significantly worse jaundice, supporting breastfeeding’s protective role.
What is 3’-sialyllactose and why is it important for babies?
3’-sialyllactose is a natural sugar found in breast milk that activates genes helping newborn intestines mature and clear bilirubin. According to 2026 research, this sugar is essential for proper intestinal development and preventing dangerous jaundice in newborns.
Can formula be supplemented with breast milk sugars to prevent jaundice?
Current research hasn’t confirmed whether adding breast milk sugars to formula provides the same benefits as breastfeeding. The 2026 study shows these sugars are important, but human studies are needed to determine if formula supplementation would be effective.
Does early nutrition affect gut health later in life?
Yes, according to 2026 research, mice deprived of the milk sugar 3’-sialyllactose in infancy showed greater intestinal vulnerability in adulthood, suggesting early nutrition shapes lifelong digestive resilience and health.
What happens to babies’ intestines when they don’t get breast milk components?
A 2026 study found that newborn mice lacking breast milk 3’-sialyllactose had immature intestines with reduced protective cells, failed to properly clear bilirubin, and activated fetal gene programs instead of maturing normally.
Want to Apply This Research?
- Track newborn bilirubin levels and feeding method (breastfeeding vs. formula) during the first two weeks of life. Record daily weight gain, feeding frequency, and any jaundice observations. Note the date jaundice resolved if present.
- For new parents using a health tracking app, log daily breastfeeding sessions and duration during the critical first two weeks. If formula feeding, note the type and volume. Record any healthcare provider visits for jaundice screening or phototherapy treatment.
- Create a long-term tracking system that monitors digestive health markers throughout infancy and childhood, including stool consistency, feeding tolerance, and any gastrointestinal issues. This allows parents to correlate early feeding choices with later digestive resilience.
This research was conducted in mice and has not yet been confirmed in human newborns. While the findings support the importance of breastfeeding, they should not replace medical advice from pediatricians or neonatologists. Parents concerned about jaundice or infant feeding should consult with their healthcare provider. This article is for educational purposes and does not constitute medical advice. Always follow guidance from qualified healthcare professionals regarding newborn care and feeding decisions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.